ABVC BioPharma Inc (ABVC)
1.065
-0.04
(-3.18%)
USD |
NASDAQ |
May 10, 16:00
1.065
0.00 (0.00%)
After-Hours: 20:00
ABVC BioPharma Cash from Investing (TTM): -0.3602M for Dec. 31, 2023
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
Date | Value |
---|---|
December 31, 2023 | -0.3602M |
September 30, 2023 | -0.5976M |
June 30, 2023 | -2.047M |
March 31, 2023 | -1.628M |
December 31, 2022 | -1.722M |
September 30, 2022 | -1.212M |
June 30, 2022 | -0.4992M |
March 31, 2022 | -0.6172M |
December 31, 2021 | -0.806M |
September 30, 2021 | -1.126M |
June 30, 2021 | -0.6807M |
March 31, 2021 | -0.5074M |
December 31, 2020 | -0.2254M |
September 30, 2020 | -0.3328M |
June 30, 2020 | 0.019M |
March 31, 2020 | -0.0175M |
December 31, 2019 | -0.0353M |
September 30, 2019 | -0.3494M |
June 30, 2019 | -0.1298M |
March 31, 2019 | -0.0178M |
December 31, 2018 | 0.00 |
September 30, 2018 | |
June 30, 2018 | |
March 31, 2018 | |
December 31, 2017 |
Date | Value |
---|---|
September 30, 2017 | |
June 30, 2017 | |
March 31, 2017 | |
December 31, 2016 | |
September 30, 2016 | |
June 30, 2016 | |
March 31, 2016 | 0.00 |
December 31, 2015 | 0.00 |
September 30, 2015 | 0.00 |
June 30, 2015 | 0.00 |
March 31, 2015 | 0.00 |
December 31, 2014 | 0.00 |
September 30, 2014 | 0.00 |
June 30, 2014 | 0.00 |
March 31, 2014 | 0.00 |
December 31, 2013 | 0.00 |
September 30, 2013 | 0.00 |
June 30, 2013 | 0.00 |
March 31, 2013 | -0.0019M |
December 31, 2012 | -0.0015M |
September 30, 2012 | -0.0195M |
June 30, 2012 | -0.0205M |
March 31, 2012 | -0.0345M |
December 31, 2011 | -0.0555M |
September 30, 2011 | -0.0387M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-2.047M
Minimum
Jun 2023
0.019M
Maximum
Jun 2020
-0.6776M
Average
-0.5074M
Median
Mar 2021
Cash from Investing (TTM) Benchmarks
NeuBase Therapeutics Inc | -0.0548M |
Sutro Biopharma Inc | -3.924M |
Reviva Pharmaceuticals Holdings Inc | -- |
Flora Growth Corp | -0.234M |
Journey Medical Corp | -5.00M |